Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Change in Medivir's Board of Directors PR Newswire STOCKHOLM, Oct. 20, 2023 STOCKHOLM, Oct. 20, 2023 /PRNewswire/ -- Medivir AB (Nasdaq: MVIR...
Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2023 PR Newswire HUDDINGE, Sweden, May...
Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ) PR Newswire STOCKHOLM, May 4, 2023...
Resolutions at the Annual General Meeting in Medivir on 4 May 2023 PR Newswire STOCKHOLM, May 4, 2023 STOCKHOLM, May 4, 2023 /PRNewswire/...
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2023 PR Newswire HUDDINGE, Sweden, April 27, 2023 HUDDINGE, Sweden, April 27, 2023 /PRNewswire/...
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple...
Medivir 2022 Annual Report published PR Newswire STOCKHOLM, April 4, 2023 STOCKHOLM, April 4, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm:...
Notice of Annual General Meeting of Medivir AB (publ) PR Newswire STOCKHOLM, March 31, 2023 STOCKHOLM, March 31, 2023 /PRNewswire/ -- The...
Medivir to present data on additive efficacy of fostrox in triple combination with anti-PD1 and kinase inhibitor in nonclinical tumor models at...
First patient dosed in the phase 2a part of Medivir's study with fostrox in combination with Lenvima® PR Newswire STOCKHOLM, March 14, 2023...
Medivir to present at the Stockholm Corporate Finance Life Science Day PR Newswire STOCKHOLM, March 8, 2023 STOCKHOLM, March 8, 2023 /PRNewswire/...
Medivir to present at the Erik Penser Bank Healthcare Day PR Newswire STOCKHOLM, Feb. 23, 2023 STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Medivir...
Pia Baumann takes up her position as Chief Medical Officer PR Newswire STOCKHOLM, Feb. 21, 2023 STOCKHOLM, Feb. 21, 2023 /PRNewswire/ -- Medivir...
Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC PR Newswire STOCKHOLM, Feb. 20, 2023...
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022 PR Newswire HUDDINGE, Sweden, Feb. 15, 2023 HUDDINGE, Sweden, Feb. 15, 2023 /PRNewswire/...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지